Login / Signup

A review of new hormonal therapies for prostate cancer in black men: is there enough data?

Matthias E MeunierPascal BlanchetYann NeuzilletThierry LebretLaurent Brureau
Published in: BMC cancer (2021)
Few articles have evaluated the effectiveness and safety of use of these treatments among black populations. The first results seem to show that Abiraterone can provide a benefit in overall survival in black populations. Prospective studies are needed to answer these questions in the future.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • electronic health record
  • big data
  • current status
  • machine learning
  • polycystic ovary syndrome
  • middle aged
  • insulin resistance